Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.31 +2.19%

+$0.43 today

Market cap
$184.89M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 0.82M

Average 0.22M

Income Statement

Follow revenue through to earnings.

Revenue

$92.39M

FY 2025 · Annual

+201.7% YoY

Operating Income

-$38.13M

FY 2025 · Annual

Net Income

-$37.71M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue12.53M13.16M21.74M30.62M92.39M
Cost of Revenue8.93M9.55M12.91M15.22M43.6M
Gross Profit3.6M3.62M8.83M15.4M48.79M
Gross Margin28.7%27.5%40.6%50.3%52.8%
Research & Development6.39M5.99M11.66M10.92M5.13M
Selling, General & Admin53.67M64.08M49.68M55.37M79.8M
Operating Expenses60.26M69.64M60.74M63.54M86.92M
Depreciation & Amortization7.35M7.54M7.79M5.93M3.78M
EBITDA(209.16M)(218.04M)(47.9M)(51.57M)(32.19M)
EBITDA Margin-1668.9%-1656.3%-220.3%-168.4%-34.8%
Operating Income(56.66M)(66.02M)(51.91M)(48.14M)(38.13M)
Operating Margin-452.1%-501.5%-238.7%-157.2%-41.3%
Interest Income201472K3.92M2.04M1.04M
Interest Expense42.23K242K119.66K203K241K
Other Income / Expenses(159.89M)(159.8M)(4.76M)(9.56M)1.92M
Income Before Tax(216.55M)(225.82M)(56.67M)(57.7M)(36.21M)
Pre-Tax Margin-1727.9%-1715.4%-260.6%-188.4%-39.2%
Income Tax Expense2.57M(245K)(269.36K)(7.87M)34K
Net Income(174.01M)(190.45M)(62.72M)(46.3M)(37.71M)
Net Margin-1388.4%-1446.8%-288.5%-151.2%-40.8%
EPS (Basic)(47.04)(37.57)(5.58)(3.64)(2.68)
EPS (Diluted)(47.04)(37.57)(5.58)(3.64)(2.68)
Weighted Avg Shares3.7M5.07M11.25M12.71M14.05M
Weighted Avg Shares (Diluted)3.7M5.07M11.25M12.71M14.05M

PRE Earnings Waterfall · TTM

NASDAQ:PRE · Revenue to Net Income

Key Ratios

EPS$-4.58
Gross Margin56.2%
Net Margin-60.7%
P/E Ratio-3.6
P/S Ratio7.6

Analysis

$113.7M of revenue converted into -$71.0M of net income for the selected period. Gross margin is 56.2% and net margin is -60.7%, showing how much revenue survives after costs and taxes. EPS is $-4.58, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingNov 2, 2026
6-K6-K filingOct 13, 2026

How much revenue does PRE generate?

Prenetics Global Limited (PRE) reported $92.39M of revenue in fiscal 2025.

Is PRE profitable?

Prenetics Global Limited (PRE) reported -$37.71M of net income, with a net margin of -40.8%.